Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Anal cancer
Results 1-25 of 30 for your search:
Start Over
Topical or Ablative Treatment in Preventing Anal Cancer in Patients with HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Age: 35 and over
Trial IDs: AMC-A01, NCI-2014-00636, NCT02135419
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer
Status: Active
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 201404101, NCI-2013-00650, NCT01790035
Phase I/II Study of PDR001 in Patients With Advanced Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CPDR001X2101, NCI-2015-00577, 2014-003929-17, NCT02404441
Surgery in Treating Patients with Early Stage Anal Canal or Perianal Cancer and HIV Infection
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: AMC-092, NCI-2014-02056, 092, NCT02437851
Stereotactic Radiosurgery in Treating Patients with Oligometastatic Disease
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-027, NCI-2014-01952, REN13120042, UPCI #10-027, NCT01345539
Stereotactic Radiosurgery in Treating Patients with Oligo-Recurrent Disease
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-028, NCI-2014-01953, REN13120040, UPCI# 10-028, NCT01345552
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 3475-158, NCI-2015-02278, 163196, 2015-002067-41, NCT02628067
Pembrolizumab in Treating Patients with Refractory Metastatic Anal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 16-301, NCI-2016-01563, NCT02919969
Cisplatin and Fluorouracil Compared with Carboplatin and Paclitaxel in Treating Patients with Inoperable Locally Recurrent or Metastatic Anal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: EA2133, NCI-2015-00771, 13/LO/1463, 2013-001949-13, 3847, CCR 3847, InterAACT CCR 3847, NCT02051868, NCT02560298
Atezolizumab and Bevacizumab in Treating Patients with Rare Solid Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2016-0861, NCI-2017-00501, NCT03074513
Ph 1 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced Gastrointestinal Malignancies
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: POLARIS2013-001, NCI-2017-00851, NCT02102022
High-Dose-Rate Brachytherapy and Chemotherapy in Treating Patients with Locally Recurrent or Residual Rectal or Anal Cancer Undergoing Non-operative Management
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 14-104, NCI-2014-01649, NCT02199236
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients with Metastatic Gastrointestinal Tumors
Status: Not yet active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2015-0152, NCI-2016-01058, NCT02757391
T-Cell Receptor Gene Therapy Targeting HPV-16 E7 with or without Pembrolizumab in Treating Patients with Metastatic, Refractory, or Recurrent HPV-Related Cancers
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 to 60
Trial IDs: 16-C-0154, NCI-2016-01170, P152617, NCT02858310
Collecting and Storing Tissue Samples from Patients with HIV-Associated Malignancies
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Tissue collection/Repository
Age: 18 and over
Trial IDs: AMC-083, NCI-2012-00718, CDR0000729843, NCT01567722
Collection of Tissue Samples in Identifying Novel Therapeutic Targets in Patients with Solid Tumors Undergoing Surgery or Biopsy
Status: Active
Phase: No phase specified
Type: Natural history/Epidemiology, Tissue collection/Repository
Age: 16 and over
Trial IDs: 12-C-0175, NCI-2015-01248, 320831, P121006, NCT01658917
Radiation Therapy, Fluorouracil, and Mitomycin in Treating Patients with Stage I-IIIB Anal Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-075, NCI-2013-01820, NCT01858025
Magnetic Resonance Imaging in Planning Radiation Therapy in Patients with Liver, Brain, Head and Neck, or Pelvic Cancer
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: UMCC 2012.113, NCI-2012-02750, HUM00068061, NCT02045381
Natural History Study of Cancer Susceptibility in Patients with Fanconi Anemia, Inherited Bone Marrow Failure Syndromes, and Family Members
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: Not specified
Trial IDs: 02-C-0052, NCI-2013-02026, CGB 7130, NCT00056121, NCT00027274
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients with Gastrointestinal or Breast Malignancies
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 2014-0250, NCI-2015-00386, NCT02221700
Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients with Cancer Undergoing Surgery
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 60 to 90
Trial IDs: CCCWFU 02114, NCI-2015-00097, NCT02356471
NanoFOD and External Beam Radiation Therapy in Monitoring Radiation Dose in Patients with Cancer
Status: Active
Phase: No phase specified
Type: Natural history/Epidemiology
Age: 18 and over
Trial IDs: Pro00061601, NCI-2015-02179, NCT02407977
Online Coping Skills Curriculum in Improving Quality of Life in Cancer Patients and Survivors with Chronic Pain
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00061381, NCI-2015-00756, NCT02465892
Assessing Quality of Life in Patients with Refractory Malignant Ascites Undergoing Peritoneal-Venous Shunt
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: UPCC 26813, NCI-2015-01009, 819053, NCT02477657
Start Over